Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

The physicochemical, biopharmaceutical, and in vitro efficacy properties of freeze-dried dexamethasone-loaded lipomers.

dc.contributor.authorPena-Rodríguez, Eloy
dc.contributor.authorMata i Ventosa, Aida
dc.contributor.authorGarcía-Vega Redondo, Laura
dc.contributor.authorPérez Torras, Sandra
dc.contributor.authorFernández Campos, Francisco
dc.date.accessioned2022-03-18T15:58:08Z
dc.date.available2022-03-18T15:58:08Z
dc.date.issued2021-08-23
dc.date.updated2022-03-18T15:58:08Z
dc.description.abstractDexamethasone-loaded polymer hybrid nanoparticles were developed as a potential tool to treat alopecia areata due to their follicular targeting ability. Freeze drying (FD) is a common technique used to improve nanoparticle stability; however, there are few studies focused on its effect on ethyl cellulose lipid-core nanoparticles. Nanoparticles were lyophilized with different cryoprotectants. Sucrose was selected because it allowed for a good resuspension and provided acceptable physicochemical parameters (374.33 nm, +34.7 mV, polydispersion 0.229%, and 98.87% encapsulation efficiency). The nanoparticles obtained were loaded into a pleasant xanthan gum hydrogel, and the rheological, release, and skin permeation profiles of different formulations were studied. The FD formulation significantly modified the particle size, and the drug release and permeation properties were also altered. In addition, analyses of the cytotoxicity and anti-inflammatory efficacy of FD and non-FD particles on human keratinocytes indicated no differences.
dc.format.extent19 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec717170
dc.identifier.issn1999-4923
dc.identifier.urihttps://hdl.handle.net/2445/184254
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/pharmaceutics13081322
dc.relation.ispartofPharmaceutics, 2021, vol. 13, num. 8, p. 1-19
dc.relation.urihttps://doi.org/10.3390/pharmaceutics13081322
dc.rightscc-by (c) Pena-Rodríguez, Eloy et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Bioquímica i Biomedicina Molecular)
dc.subject.classificationLiofilització
dc.subject.classificationNanopartícules
dc.subject.otherFreeze-drying
dc.subject.otherNanoparticles
dc.titleThe physicochemical, biopharmaceutical, and in vitro efficacy properties of freeze-dried dexamethasone-loaded lipomers.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
717170.pdf
Mida:
3.26 MB
Format:
Adobe Portable Document Format